Shares of AmerisourceBergen fell more than 7 percent Thursday after the company lowered its full-year earnings forecast.
The drug wholesale company slashed diluted earnings per share expectations by 10 cents to $5.44. Overall results were mixed; AmerisourceBergen beat analyst estimates by 9 cents a share, earning an adjusted $1.68 per share in the second quarter for this fiscal year. Quarterly revenue was just below forecasts at $35.7 billion, up 9.3 percent year-over-year.
The Pennsylvania-based company's stock is down more than 25 percent so far this year. Shares of AmerisourceBergen traded around $77 before the close Thursday, down from its 52-week high of $116 dollars.